New drug approvals: April 2018
April has seen some interesting drug approvals, including treatments for X-linked hypophosphatemia, idiopathic thrombocytopenic purpura and nausea; find out more in this round-up of the new therapies on the market.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.